Načítá se...
Difluprednate for the prevention of ocular inflammation postsurgery: an update
PURPOSE: To review the most recent published data regarding the novel potent steroid, difluprednate ophthalmic emulsion, 0.05%. METHODS: A comprehensive search of recent published literature including difluprednate was performed. Clinical studies relevant to the characteristics and clinical efficacy...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3130919/ https://ncbi.nlm.nih.gov/pubmed/21750615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S6541 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|